Usability of FDA-approved medication guides
- PMID: 22566170
- PMCID: PMC3509312
- DOI: 10.1007/s11606-012-2068-7
Usability of FDA-approved medication guides
Abstract
Background: Medication guides are required documents to be distributed to patients in order to convey serious risks associated with certain prescribed medicines. Little is known about the effectiveness of this information to adequately inform patients on safe use.
Objective: To examine the readability, suitability, and comprehensibility of medication guides, particularly for those with limited literacy.
Design: Assessments of suitability and readability of 185 medication guides, and a sub-study examining change in suitability and readability from 2006 to 2010 among 32 of the medication guides (Study 1); 'open book' comprehension assessment of medication guides (Study 2).
Setting: Two general internal medicine clinics in Chicago, IL.
Patients: Four hundred and forty-nine adults seeking primary care services, ages 18-85.
Measurements: For Study 1, the Suitability Assessment of Materials (SAM) and Lexile score for readability. For Study 2, a tailored comprehension assessment of content found in three representative medication guides.
Results: The 185 analyzed medication guides were on average 1923 words (SD = 1022), with a mean reading level of 10-11th grade. Only one medication guide was deemed suitable in SAM analyses. None provided summaries or reviews, or framed the context first, while very few were rated as having made the purpose evident (8 %), or limited the scope of content (22 %). For Study 2, participants' comprehension of medication guides was poor (M = 52.7 % correct responses, SD = 22.6). In multivariable analysis, low and marginal literacy were independently associated with poorer understanding (β = -14.3, 95 % CI -18.0 - -10.6, p < 0.001; low: β = -23.7, 95 % CI -28.3 - -19.0, p < 0.001).
Conclusion: Current medication guides are of little value to patients, as they are too complex and difficult to understand especially for individuals with limited literacy. Explicit guidance is offered for improving these print materials.
Figures
Comment in
-
Getting to better prescription drug information.J Gen Intern Med. 2012 Dec;27(12):1582-4. doi: 10.1007/s11606-012-2222-2. J Gen Intern Med. 2012. PMID: 23129158 Free PMC article. No abstract available.
References
-
- Department of Health and Human Services Prescription drug product labeling: medication guide requirements; final rule. Fed Regist. 1998;63:66378–400. - PubMed
-
- Department of Health and Human Services. medication guides for Prescription Drug Products. Title 21 Code of Federal Regulations. Pt. 208. 2004:115-6.
-
- U.S. Food and Drug Administration. Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments and Proposed REMS Modifications. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati.... Accessed March 29, 2012
-
- U.S. Food and Drug Administration, Center for Drug Evaluation Research (CDER). Guidance for Industry: medication guides - Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati.... Accessed March 29, 2012.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical